185 related articles for article (PubMed ID: 34419110)
1. The use of fibrinolytic therapy for parapneumonic effusion in pregnancy: a case report and a review.
Nasralla A; Laing B; Turner SR
J Cardiothorac Surg; 2021 Aug; 16(1):236. PubMed ID: 34419110
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of intrapleural instillation of fibrinolytics for treating pleural empyema and parapneumonic effusion: a meta-analysis of randomized control trials.
Nie W; Liu Y; Ye J; Shi L; Shao F; Ying K; Zhang R
Clin Respir J; 2014 Jul; 8(3):281-91. PubMed ID: 24428897
[TBL] [Abstract][Full Text] [Related]
3. Update on the role of intrapleural fibrinolytic therapy in the management of complicated parapneumonic effusions and empyema.
Singh G; Pitoyo CW; Nasir AU; Rumende CM; Amin Z
Acta Med Indones; 2012 Jul; 44(3):258-64. PubMed ID: 22983084
[TBL] [Abstract][Full Text] [Related]
4. Fibrinolytics in the treatment of parapneumonic effusions.
Bouros D; Schiza S; Siafakas N
Monaldi Arch Chest Dis; 1999 Jun; 54(3):258-63. PubMed ID: 10441983
[TBL] [Abstract][Full Text] [Related]
5. Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema.
Altmann ES; Crossingham I; Wilson S; Davies HR
Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684683
[TBL] [Abstract][Full Text] [Related]
6. Intrapleural streptokinase for the treatment of complicated parapneumonic effusion and empyema in 2 newborns.
Yigit AK; Yilmaz Y; Erdeve O; Gokce IK; Oguz SS; Uras N; Dilmen U
J Pediatr Surg; 2012 Oct; 47(10):e41-4. PubMed ID: 23084230
[TBL] [Abstract][Full Text] [Related]
7. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema.
Cameron R; Davies HR
Cochrane Database Syst Rev; 2008 Apr; (2):CD002312. PubMed ID: 18425881
[TBL] [Abstract][Full Text] [Related]
8. [Using of fibrinolytics in the treatment of complicated parapneumonic effusion and empyema in children].
Uyan AP; Ozyürek H; Yilmaz E
Tuberk Toraks; 2003; 51(3):320-4. PubMed ID: 15143413
[TBL] [Abstract][Full Text] [Related]
9. [Fibrinolytics in the Treatment of Complicated Pleural Effusions].
Coelho A; Coelho M; Pereira J; Lavrador V; Morais L; Carvalho F
Acta Med Port; 2016 Nov; 29(11):711-715. PubMed ID: 28229836
[TBL] [Abstract][Full Text] [Related]
10. Intrapleural fibrinolytic agents for empyema and complicated parapneumonic effusions: a meta-analysis.
Tokuda Y; Matsushima D; Stein GH; Miyagi S
Chest; 2006 Mar; 129(3):783-90. PubMed ID: 16537882
[TBL] [Abstract][Full Text] [Related]
11. Complicated parapneumonic effusion and empyema thoracis: microbiology and predictors of adverse outcomes.
Tsang KY; Leung WS; Chan VL; Lin AW; Chu CM
Hong Kong Med J; 2007 Jun; 13(3):178-86. PubMed ID: 17548905
[TBL] [Abstract][Full Text] [Related]
12. Intra-pleural fibrinolytic therapy vs. conservative management in the treatment of parapneumonic effusions and empyema.
Cameron R
Cochrane Database Syst Rev; 2000; (3):CD002312. PubMed ID: 10908554
[TBL] [Abstract][Full Text] [Related]
13. Intrapleural Fibrinolytic Therapy for Empyema and Pleural Loculation: Knowns and Unknowns.
Idell S; Rahman NM
Ann Am Thorac Soc; 2018 May; 15(5):515-517. PubMed ID: 29361235
[No Abstract] [Full Text] [Related]
14. Intrapleural fibrinolytic therapy in complicated parapneumonic effusion and empyema: present status.
Barthwal MS
Indian J Chest Dis Allied Sci; 2008; 50(3):277-82. PubMed ID: 18630794
[TBL] [Abstract][Full Text] [Related]
15. Intrapleural Fibrinolysis with Urokinase Versus Alteplase in Complicated Parapneumonic Pleural Effusions and Empyemas: A Prospective Randomized Study.
Alemán C; Porcel JM; Alegre J; Ruiz E; Bielsa S; Andreu J; Deu M; Suñé P; Martínez-Sogués M; López I; Pallisa E; Schoenenberger JA; Bruno Montoro J; de Sevilla TF
Lung; 2015 Dec; 193(6):993-1000. PubMed ID: 26423784
[TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapy in complicated parapneumonic pleural effusions and thoracic empyema.
Schiza SE; Antoniou KM; Economidou FN; Siafakas NM
Pulm Pharmacol Ther; 2005; 18(6):381-9. PubMed ID: 15998594
[TBL] [Abstract][Full Text] [Related]
17. Tissue plasminogen activator for the treatment of parapneumonic effusions in pediatric patients.
Israel EN; Blackmer AB
Pharmacotherapy; 2014 May; 34(5):521-32. PubMed ID: 24390857
[TBL] [Abstract][Full Text] [Related]
18. Choice of intrapleural fibrinolytic agents in the treatment of adult complicated parapneumonic effusion and empyema: Network meta-analysis.
Yokoyama Y; Kuno T; Takagi H; Burfeind W
Asian Cardiovasc Thorac Ann; 2023 Jun; 31(5):451-458. PubMed ID: 37287257
[TBL] [Abstract][Full Text] [Related]
19. Minimally invasive treatment of complicated parapneumonic effusions and empyemas in adults.
Porcel JM
Clin Respir J; 2018 Apr; 12(4):1361-1366. PubMed ID: 29087029
[TBL] [Abstract][Full Text] [Related]
20. Fibrinolytic therapy for parapneumonic effusion and empyema.
Khilnani GC
Indian J Chest Dis Allied Sci; 2002; 44(2):81-4. PubMed ID: 12026256
[No Abstract] [Full Text] [Related]
[Next] [New Search]
